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The acute cellular electrophysiologic actions of amio-
darone on Isolated neonatal and adult canine ventricular
muscle and Purkinje fibers were evaluated using stan-
dard microelectrode techniques. Amiodarone, 10-6 to 5
X 10-5 M (0.68 to 34 Itg/ml), significantly (p < 0.05)
prolonged' adult ventricular muscle action potential du-
ration 'and voltage-dependent refractoriness at all con-
centrations, thereby demonstrating typical class III an-
tiarrhythmic effects. Similar concentrations had no
significant effects on neonatal ventricular muscle. Amlo-
darone significantly shortened action potential duration
and refractoriness of both neonatal and adult Purkinje
fibers, with neonatal fibers having a greater sensitivity
to the drug. At the standard stimulation rate of I Hz,
Amiodarone hydrochloride has recently been the subject of
considerable experimental and clinical interest. Extensive
investigative studies (1-8) in adult patients have docu-
mented its efficacy in controlling most supraventricular and
ventricular arrhythmias. The fundamental basis for the an-
tiarrhythmic potential of amiodarone is not known, but has
been related to its propensity to induce prolongation of ac-
tion potential duration and voltage-dependent refractoriness
(9) . Recent preliminary report s (\0,11) have suggested that
amiodarone may also exert significant frequency-dependent
class I antiarrhythmic action s. Its recent use in children has
shown that amiodarone is extremely potent against nearly
all childhood arrhythmias refractory to more traditional
pharm acologic agents and is associated with few significant
adver se reaction s (12-15) .
Little is known regarding the cellul ar and ionic mecha-
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amiodarone had no effects on action potential amplitude
or maximal rate of rise of phase 0 of the action potential
(Vmax) of any tissues. At faster stimulation frequencies
(2 to 4 Hz), amiodarone produced frequency-dependent
decreases in action potential amplitude and Vmax of all
neonatal and adult preparations.
The data indicate that amiodarone exhibits a complex
aggregate of electrophysiologic actions that include sig-
nificant frequency-related class I effects. Compared with
adult myocardium, neonatal tissues demonstrated al-
tered responsiveness to amiodarone, a feature common
to many antiarrhythmic compounds.
(J Am Coil Cardiol 1985;5:1109-15)
nisms underlying the electrophysiologic actions of amio-
darone . Its effects on the developing myocardium and spe-
cialized conduction system are also unknown. Previous clinical
and in vitro electrophysiologic studies (16-18) have pro-
vided convincing evidence that the response of the immature
heart to most antiarrhythmic agent s differs greatly from that
of the adult heart. Because a proposed mechanism for the
action of amiodarone relates to an increase in the deacti-
vation time constant of the delayed outward (K +) current
and since adult and neonatal conducting tissues demonstrate
marked differences in intracellular potassium activity and
nux (19) , it seems reasonable to assume that amiodarone
may also affect mature and immature cardiac tissues dif-
ferently. The purpose of this study was to compare the acute
electrophysiologic action s of amiodarone on adult and neo-
natal cardiac tissues using transmembrane action potential
recordings from isolated tissues superfused with variou s
drug concentrations .
Methods
Preparation. We utilized healthy adult and neonatal ( I
to 10 days of age) mongrel dogs of either sex. After anes-
thesia with intravenous (adults) or intraperitoneal (neonates)
pentobarbital, 40 rng/kg, the hearts were rapidly removed
through a lateral thoracotomy (adults) or median sternotomy
0735-1097/851$3.30
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(neonates)and placed in cool, oxygenated (95% oxygen and
5% carbon dioxide) Tyrode's solution. Further dissection
resulted in preparations that included a right ventricular
papillary muscle and a portion of the endocardial right ven-
tricular free wall with the interveningfalse tendonsattached.
The proximal and distal muscle islands were pinned to the
paraffin base of a 10 ml Lucite tissue chamber, leaving the
free-running Purkinje fibers undisturbed and entirely sur-
rounded by Tyrodes solution. The Tyrodes solution had a
pH of 7.40 ± 0.02 and the following composition (mM):
sodium chloride, 130; potassium chloride, 4.0; calcium
chloride, 1.8; magnesium sulfate, 0.5; monosodium phos-
phate, 1.8; glucose, 5.5 and sodium bicarbonate, 18.0. Flow
rate through the tissue chamber was 10 to 15 mllmin and
temperature was maintained at 35.5 ± 0.5°C.
Electrical stimulation and recording techniques.
Electrical stimulation at I Hz (I ,000 ms cycle length) was
carried out from the papillary muscle at its junction with
the proximal free-running Purkinje fiber bundle. This re-
sulted in direct stimulation of the papillary muscle and,
through anterograde Purkinje fiber conduction, indirect
stimulation of the distal ventricular myocardium. Prepara-
tions were stimulated using Teflon-coated, bipolar silver
wire electrodes connected by way of a stimulus isolation
unit to a Grass S-88 stimulator. Impulses of 2 ms duration
and twice diastolic threshold current were utilized. To ex-
amine the frequency-dependent effects on ventricular mus-
cle and Purkinje fiber action potential variables. some prep-
arations were stimulated for I to 2 minutes at 2, 3 and 4
Hz during the control period and after amiodarone therapy.
Effective refractory periods were determined by introduc-
ing, after every 8 to 10 basic driven beats, extrastimuli
having progressively shorter coupling intervals. The effec-
tive refractory period was defined as the shortest premature
interval producing a response that depolarized to values
more positive than 0 mV.
Transmembrane action potentials were recorded using 3
M potassium chloride-filled glass capillary microelectrodes
having tip resistances of 10 to 30 megaohm. The micro-
electrodes were coupled by a silver-silver chloride junction
and an intracellular probe system to an amplifier with high
input impedance and input capacity neutralization (Mentor
N-950). An electronic differentiating circuit (time constant
= 20 jLs) was used to determine the maximal rate of rise
of phase 0 of the action potential (Vmax). The system was
calibrated using a 10mV internal signal. The action potential
and Vmax tracings were continuously displayed on a storage
oscilloscope (Tektronix R564B) and photographed on Po-
laroid film.
Ventricular muscle action potentials were obtained from
the papillary muscle at a site near the stimulating electrode.
Free-running Purkinje fiber action potentials were recorded
from the distal false tendon near its insertion into the right
ventricular myocardium, the area of maximal action poten-
tial duration. Distal subendocardial Purkinje fiber action
potentials were recorded from the endocardial surface of the
right ventricular free wall at sites at least 5 mm distal or
lateral to the observed subendocardial Purkinje fiber bundles.
Amiodarone superfusion. Amiodarone is insoluble in
physiologic solution and was, therefore, initially dissolved
in ethanol and homologous serum as described and utilized
by Polster and Broekhuysen (20). In brief, 6.82 mg of pure
amiodarone (Labaz-Sanofi Laboratories. Belgium) was dis-
solved in I ml of 50% ethanol. Of this, 0.5 ml was added
to 4.5 ml homologouscanine serum to make a 10 ] M stock
solution. Final concentrations of 10 (, to 5 x 10 5 M
(equivalent to 0.68 to 34 jLg/ml) were made in Tyrodc's
solution. Usingthis technique, the superfusion medium con-
taining various drugconcentrations remained clearand showed
no evidence of drug precipitation throughout the experiments.
Control action potentials were photographedafter at least
I hour of equilibration. Repeat recordings were obtained
after 45 to 60 minutes of superfusion with each drug con-
centration. which was increased in a stepwise fashion by
the method of cumulative addition. Equivalent concentra-
tions of ethanol and homologous canine serum without
amiodarone were found to have no effect on the action
potential variables of five adult ventricular muscle
preparations.
Measurements and data analysis. Variables measured
from myocardial and Purkinje fiber action potentials were:
maximal diastolic potential, measured from the 0 potential
to the point of maximal electronegativity; action potential
amplitude, measured from the maximal diastolic potential
to the peak of the action potential; overshoot. measured
from the 0 potential to the action potential peak; upstroke
velocity of phase 0 rvnlilx); action potential duration at 50
(APD50 ) and 90% (APD,/o) repolarization; and effective re-
fractory period.
To compare control neonatal and adult transmembrane
action potential characteristics, we utilized a { test for un-
paired data. The effects of amiodarone on action potential
variableswere compared withcontrol, pre-drug values using
a { test for paired data. All analyses were made using raw
data. Two-tailed tests were used and a probability of less
than 0.05 was considered statistically significant.
Results
Control data. During control superfusion, neonatal
ventricular muscle action potential characteristics differed
significantly from those obtained from adult preparations.
Table I lists the control values; Figure I, taken from typical
experiments, illustrates the majordifferences . Neonatal muscle
fibers showed a significantly (p < 0.05) less negative max-
imal diastolic potential, lower action potential amplitude
and Vmax and significantly longer values for APD5o , APD9()
and effective refractoryperiod. Additionally, neonatal fibers
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Table l , Effects of Amiodarone on Adult and Neonatal Ventricular Muscle Action Potential Characteristics
Adult YM (n ~ 9)
Control
10 ' M
\0 ;M
5 x 10 ' M
Neonatal YM (n = 7)
Control
10 ' M
10 ' M
5 x 10 ' M
APA
(rnv)
101.3 ± 3.9
101.4 ± 5.H
101.6 ± 5.H
IOU ± 5.7
93 .7 ± 3.6
99.4 :!. 4 .8
102.1 :!. 4 .2
101. 8 -+ 3.5
MDP
( - mY)
79.H ± 1.9
79. 1 ± 3.2
79.8 ± 2.0
79.4 ± 2.6
76 .5 ± 2.4
77 .0 ± 3.0
79.4 ± 2.0
7/LO .!. 3.2
Overshoot
un v )
2 1.6 ± 3.2
22.3 ± 2.9
21.H ± 4.7
22.3 i: 3.6
20.8 ± 2.8
22.4 ± 2.5
22.8 .!. 2.8
238 ± 2.3
" Il M \
(Y/s)
177. 2 -+. 35.3
159.4 :!: 64.6
158.2 i: 42.7
176.8 ± 6.'.6
146.0 :!: 84.7
16 1.6 :!: 53.9
16/L() ± 46 .2
134.9 ! : 21.9
APD",
( rns)
145.8 :!: 29.6
163.2 :!. 25.4*
169.4 ± 27.3*
174.4 -+ 22.3*
158.2 :!. 30.5
171.2 ± 27.6
171.3 ± 19 .7
\65.9 ± 2l.8
APD""
( ms)
183.1 ± 29. 1
200.7 ± 27.6*
208.2 "t 25.3*
2 14. 1 ± 2 1.1*
208.9 T 30.8
220.3 -+ 27.3
222.7 .!. 18.9
223.9 ± 21.1
ERP
( rns)
194.9 ± 26.8
2 12.0 ± 25.3*
2 17.6 ± 27.3*
223.8 :!: 23.8*
225.3 ± 25.7
220.9 ± 14.2
229.9 ± 22.9
232.3 ± 23.9
*p < 0.01 compared with control state. APA = action potential amplitude: APD;o -, action potential duration at 50% rcpolarization: APD9() =
action potential duration at 90% repolarization: ERP = effective refractory period: MDP = maximal diastolic potential: YM = ventricular muscle: Vrna'
= maximal rate of rise of phase 0 of the action potential.
consistently lacked the phase I . .notch" that is characteristic
and well defined in adult ventricular muscle.
Free-running Purkinje fiber action potential character-
istics also differed significantly between neonatal and adult
preparations (Table 2; Fig. 2). Neonatal fi bers had a sig-
nificantly less negative maximal diastolic potential, lower
action potential amplitude. overshoot and Vma, and shorter
values for APD5(), APDl)() and effective refractory period.
In neonatal Purkinje fibers. phases I and 2 occurred at more
positive membrane potentials than they did in adult
preparations.
Amiodarone effects on ventricular myocardium.
Table I summarizes the effects produced by acute exposure
to amiodarone on nine adult and seven neonatal ventricular
muscle preparations. Figure I. taken from typical experi-
ments. illustrates the effects of the highest amiodarone con-
centration. At a constant pacing rate of I Hz. amiodarone
did not significantly affect action potential amplitude. max-
imal diastolic potential. overshoot or V""" in either neonatal
or adult preparations. The major effect on adult tissues was
on rcpolarization. Although APD511. APD90 and effective
refractory period were significantly greater than control val-
ues at each amiodarone concentration. the largest increases
(\ 1.9. 9.6 and 8.8% for APD5llo APDl)(J and effective re-
fractory period. respectively) occurred at the lowest con-
centration (10 h M or 0.68 p.g/m l) . The ratio of effective
refractory period to APDl)(' remained unchanged ( 1.06 ±
0.0 Il, thereby supporting the voltage-dependent nature of
the amiodarone-induced increases in effective refractory pe-
riod in adult myocardium.
In neonatal ventricular muscle action potentials , repo-
larization and refractoriness were not affected by arnioda-
roncoThere were no significant arniodarone-induced changes
in APD~l lo APD,x, or effective refractory period at any drug
concentration (Table I). These values increased by only 4.9.
7.2 and 3.1%. respectively. after 5 x 10 5M (34 p.g/ml)
amiodarone. The representative experiment shown in Figure
I illustrates virtually identical neonatal ventricular muscle
ADULT NEONATAL
Figure I, Action potential recordingsfrom single
adult and neonatal papillary muscle cells during
the control period and after the highest amioda-
rone (Arnie) concentration. In this and all sub-
sequentfigures of intracellularrecordings. the lower
tracing in each panel showsthe upstroke velocity
of phase 0 (Vmn) andthesecondaction potential
in each panel defines the effective refractory pe-
riod. Voltage and time calibrations are the same
in each panel.
Control
Amio 5Xl0 -'
lOOms
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action potential characteristics during the control period and
after 5 X 10 5 M of amiodarone.
Amiodarone effects on Purkinje fibers. The acute ef-
fects of amiodarone on eight adult and eight neonatal free-
running Purkinje fibers are summarized in Table 2. Typical
experiments are illustrated in Figure 2. In the three con-
centrations utilized, amiodarone had no effect on Purkinje
fiber action potential amplitude, maximal diastolic potential,
overshoot or Vmax of either adult or neonatal preparations
paced at I Hz. Amiodarone did, however, acutely decrease
the action potential duration and refractoriness of all prep-
arations in a concentration-dependent manner. These effects
were paradoxical compared with those produced in adult
ventricular muscle. The amiodarone-induced decreases in
APD 50 exceeded those of APD9(), resulting in action poten-
tials having an abbreviated plateau and a more gradual tran-
sition between phases 2 and 3. Additionally, amiodarone
induced a concentration-dependent increase (greater nega-
tivity) in plateau potential in both adult and neonatal fibers
(Fig. 2). Amiodarone's shortening effect on repolarization
and refractoriness was greater in neonatal Purkinje fibers.
At the lowest concentration (10- 6 M), amiodarone signif-
icantly shortened APD 50 ( - 2 I. 1%), APD 90 ( - 12.8%) and
effective refractory period (- 12.8%) of neonatal Purkinje
fibers, whereas in adult tissues, the effects were minimal
and insignificant. The preferentially greater effects on re-
polarization of neonatal tissues were also apparent at the
middle amiodarone concentration. At the highest concen-
tration (5 X 10- 5 M), the effects of amiodarone on neonatal
and adult Purkinje fiber repolarization and refractoriness
were similar.
The differential effects ofamiodarone on distal free-run-
ning and distal subendocardial Purkinje fibers were eval-
uated in four neonatal preparations. One of these experi-
ments is illustrated in Figure 3. During control superfusion,
distal subendocardial fibers had significantly (p < 0.05)
shorter values for APD 5o, APD 90 and effective refractory
period compared with free-running Purkinje fibers, findings
consistent with previous observations (21). Action potential
duration at 90% repolarization and effective refractory pe-
riod from distal subendocardial fibers were 16.3 and 12.9%,
respectively, shorter than corresponding values from free-
running fibers. Amiodarone produced concentration-depen-
dent decreases in action potential duration and refractoriness
of all distal subendocardial Purkinje fibers. These decreases,
however, were much less than those produced in the free-
running Purkinje fibers from the same preparations, result-
ing in a decrease in the dispersion of action potential du-
ration and refractoriness between the two sites. After admin-
istration of 5 X 10- 5 M amiodarone, mean values for APD9()
and effective refractory period from distal subendocardial
sites measured - 6.3 and + 1.5%, respectively, of cor-
responding values from free-running fibers (p > 0.05). Fig-
ure 3 illustrates the lesser effect of amiodarone on distal
subendocardial fibers and demonstrates the obliteration of
the dispersion of refractoriness that occurs normally in the
neonatal specialized conduction system.
Frequency-dependent effects. The effects of increased
stimulation frequency on amiodarone-induced changes in
action potential variables were evaluated in 10 Purkinje fiber
(6 adult and 4 neonatal) and 8 ventricular muscle (5 adult
and 3 neonatal) preparations. Results from adults and neo-
nates were quantitatively similar (when expressed as percent
change) and are considered together. Figure 4 illustrates
typical adult action potentials at stimulation rates of I Hz
and after I to 2 minutes of stimulation at 2, 3 and 4 Hz
during the control period and after I hour of superfusion
with 5 x 10- 5 M of amiodarone. The reductions in APD 50
and APD 90 resulting from higher rates of stimulation were
not significantly altered by amiodarone. Before the admin-
istration of amiodarone, stimulation rates up to 4 Hz did
not significantly affect the action potential amplitude or
Vmax of either ventricular muscle or free-running Purkinje
fiber action potentials. A slight but insignificant decrease in
Vmax was occasionally seen in both tissues at 4 Hz. After
amiodarone administration, action potential amplitude and
Vmax were not altered significantly when stimulated at I Hz.
More rapid rates of stimulation, however, resulted in pro-
gressive and significant reductions of both variables. In Pur-
kinje fibers, stimulation at 4 Hz after amiodarone admin-
Table 2. Effects of Amiodarone on Adult and Neonatal Purkinje Fiber Action Potential Characteristics
APA MDP Overshoot Vmax APD50 APD90 ERP
(mY) (-mY) (rnv) (Y/s) (rns) (ms) (ms)
Adult PF (n = 8)
Control 118.9::!: 3.3 86.1 ::!: 1.9 33.0 ::!: 1.6 398.8 ::!: 85.7 228.8 ::!: 35.0 307.1 ::!: 34.3 298.1 ::!: 34.9
10 6M 117.1 ::!: 3.6 86.1 ::!: 2.2 31.0::!: 1.9 370.3 ::!: 84.6 217.5 ::!: 40.4 305.4 ::!: 37.5 296.3 ::!: 41.5
10 5M 118.1 ::!: 2.9 86.0 ::!: 1.3 32.0 ::!: 1.9 396.4 ::!: 61.9 184.6 ± 36.6+ 283.1 ± 32.5" 281.0 ::!: 39.8
5 x lO- sM 115.4::!:2.7 83.8 ::!: 1.3 31.6 ::!: 3.2 392.4 ::!: 56.1 137.9 ± 23.2+ 253.5 ::!: 25.4+ 266.8 ::!: 36.0·
Neonatal PF (n = 8)
Control 108.8 ::!: 4.9 80.5 ::!: 1.7 28.4 ::!: 3.8 335.8 ::!: 97.3 194.6 ::!: 43.0 249.7 ::!: 46.3 248.6 ::!: 44.3
10 6M Ill.9 ::!: 2.8 82.6 ::!: 2.1 29.3 ::!: 1.2 352.0 ::!: 51.7 153.5 ::!: 15.5" 217.8 ::!: 18.4" 216.8 ::!: 11.3"
lO- sM 108.6 ::!: 5.4 80.8 ::!: 3.4 27.8 ::!: 2.7 323.6 ::!: 72.9 123.5 ::!: 21.6+ 208.5 ::!: 11.0" 212.7:!: 15.5"
5 x 10 sM 104.8 ::!: 5.3 79.4 ::!: 3.5 25.5 ::!: 3.0 315.8 ::!: 74.3 89.7 ::!: 31.7+ 194.9 ::!: 20.7+ 212.2::!: 14.9"
"p < 0.05; +p < 0.01 compared with control state. PF = Purkinje fibers; other abbreviations as in Table I.
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1 20 0 VIS
Figure 2. Effects of increasing amiodarone concen-
trations on adult and neonatal Purkinje fiber action
potentials. Voltage and time calibrations are the same
in each panel.
ADULT NEONATAL
100m.
o
mV
-60
istration resulted in a mean value for Vmax (308 ± 97 VIs).
which was 59% of that recorded at I Hz and 67% of that
recorded at the same rate before amiodarone treatment. In
ventricular muscle. average Vmax at 4 Hz after amiodarone
administration (78 ± 24 VIs) was 60% of that at I Hz and
50% of that recorded before amiodarone treatment at the
same stimulation frequency.
Discussion
Categorization of amiodarone as a so-called class III an-
tiarrhythmic agent is based predominantly on data derived
from patients receiving long-term therapy and from in vitro
studies of chronically treated animals (2.4.9). Despite con-
tinued controversy regarding amiodarone ' s efficacy when
Figure 3. Transmembrane action potential re-
cordings from distal free-running (left) and distal
subendocardial (right) Purkinje fibers (PF) from
a neonatalheart. Before amiodarone(control). there
is marked dispersion in action potential duration
and refractoriness between the two sites. After 5
x 10' 5 M amiodarone (Amio) administration.
action potentials demonstrate nearly equal dura-
tions and effective refractory periods. Voltage and
time calibrations arc the same in each panel.
Control
Amio 5 X10-'
Subendocardial PF
100ms
1114
-6
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Figure 4. The effects of increasing stimulation rates
on Purkinje fiber and ventricular muscleaction poten-
tials and Vrna. before (control) and after superfusion
with 5 x 10 5 M amiodarone. In each panel, action
potentials areshown from Iertto right after 60 seconds
of pacing at 1, 2. 3 and 4 Hz, respectively. A single
cell was impaled continuously for each experiment.
Voltage and time calibrations are the same for each
panel.
administered acutely. there have been few studies of its acute
electrophysiologic actions.
Amiodarone effects on ventricular myocardium. In
adult ventricular myocardium. amiodarone exhibited typical
class III antiarrhythmic actions in that it lengthened action
potential duration and voltage-dependent refractoriness. At
a stimulation frequency of I Hz. amiodarone had no effect
on action potential amplitude. overshoot. maximal diastolic
potential. Vrna . or time-dependent refractoriness. The lack
of class I antiarrhythmic effects at the standard stimulation
rate is in agreement with previous data showing that the
fundamental action of amiodarone on adult cardiac muscle
is to lengthen repolarization homogeneously. Our data using
neonatal ventricular muscle indicate a markedly decreased
sensitivity to amiodarone. For example. even at the highest
concentration (34 jlg/ml). amiodarone was devoid of clec-
trophysiologic effects.
Paradoxical effects of amiodarone on Purkinje fi-
bers. In contrast to its effects on ventricular muscle. arnio-
darone produced a significant shortening of repolarization
and voltage-dependent refractoriness in Purkinje fibers. Al-
though evident in both adult and neonatal tissues. this effect
was quantitatively greater in immature Purkinje fibers . Al-
though amiodarone's propensity to lengthen repolarization
is well documented. little direct evidence has emerged to
suggest that His-Purkinje system refractoriness is also
lengthened. Recent, preliminary in vitro studies from other
institutions (11.12) lend support to our conclusions regard-
ing amiodarone's acute shortening effect on Purkinje tiber
repolarization.
Rate-related effects. Our findingof a frequency-related
effect on the action potential amplitude and Villa. of all
neonatal and adult tissues clearly indicates that amiodarone
exhibits class I activity. Unlike conventional class I antiar-
rhythmic agents. however, amiodarone's effects are evi-
dent only at higher stimulation frequencies and appear not
to be age-related. Similar findings have been reported by
Mason et al. (10) using adult Purkinje fibers. Using voltage
clamp techniques. they showed that amiodarone produced
a rate-dependent blockade of inactivated sodium channels.
Clinical implications. Our studies indicate that the elec-
trophysiologic actions of amiodarone are broader than pre-
viously appreciated. The uniform prolongation of myo-
cardial action potential duration and refractoriness in adults
may be responsible for amiodarone's efficacy against atrial
and ventricular muscle reentrant arrhythmias. Its acute in-
travenous effects against ventricular arrhythmias. as re-
ported in some studies (23,24), may be related to an acute
reduction in the dispersion of refractoriness that normally
exists between ventricular myocardium and the specialized
conduction system in adulls. Since neonatal Purkinje fiber
action potentials are significantly shorter compared with
those in adults, the normal dispersion of refractoriness is
considerably smaller in the immature heart. Although arnio-
darone had no effect on neonatal ventricular muscle. the
significant decrease in Purkinje fiber action potential du-
ration is likely to further reduce the existing dispersion of
refractoriness. Moreover. the virtual elimination by arnio-
darone of the normal dispersion of refractoriness between
distal free-running and distal subendocardial Purkinje fiber
action potentials in the immature heart may contribute fur-
ther to the drug's efficacy in young children.
Ofgreatest potential significance are amiodarone' s heart
rate-related class / antiarrhythmic actions . Our data suggest
that this agent has greater antiarrhythmic efficacy in the
treatment of arrhythmias having faster rates. as may occur
in infants and small children. The inability to demonstrate
any acute class III antiarrhythmic effects on neonatal tissues
suggests the possibility that amiodarone's clinical effec-
tiveness in infants and children may be related predomi-
nantly to its class I antiarrhythmic activity. In adults, the
increase in action potential duration induced by amiodarone
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may potentiate the drug's class I antiarrhythmic actions by
prolonging the periodduring which sodium channels remain
inactivated. Finally, the antiarrhythmic potential of the drug's
noncompetitiveantiadrenergic actions cannot be ignored. It
must be remembered that these studies, conducted on normal
tissues, may not accurately reflect amiodarone's effects on
diseased cardiac tissues.
We are gra teful to Lucy Parr ish for her assistance in the preparation of
this manuscri pt.
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